DEMO

Log In | Sign Up



Abbott Laboratories

Selected Articles

2025-08-14
ETF Daily News
Rep. Josh Gottheimer Sells Natera, Inc. (NASDAQ:NTRA) Stock
2025-08-14
ETF Daily News
Rep. Josh Gottheimer Sells Off Shares of International Business Machines Corporation (NYSE:IBM)
2025-08-14
ETF Daily News
Rep. Josh Gottheimer Sells Off Shares of Independence Realty Trust, Inc. (NYSE:IRT)
2025-08-13
GlobeNewswire
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight
2025-08-13
GlobeNewswire
Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi
2025-08-13
GlobeNewswire
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
2025-08-13
ETF Daily News
Walmart (NYSE:WMT) Shares Unloaded Rep. Josh Gottheimer
2025-08-13
ETF Daily News
Visa (NYSE:V) Stock Unloaded Rep. Josh Gottheimer
2025-08-13
ETF Daily News
Rep. Josh Gottheimer Sells Abbott Laboratories (NYSE:ABT) Shares
2025-08-12
GlobeNewswire
In Vitro Diagnostics Market Size to Exceed USD 132.18 Bn by 2034

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. US0028241000 www.abbott.com